Clinical Trial Update: Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) [Phase 3]

View source ↗

Summary

Phase 3 trial update of ceftolozane/tazobactam in Japanese participants with uncomplicated pyelonephritis and complicated urinary tract infection; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Urinary Tract Infection
• Pyelonephritis
• Uncomplicated Pyelonephritis
• Urinary Tract Infection

Drugs mentioned

• Ceftolozane/Tazobactam (ceftolozane/tazobactam)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Tract Infection (UTI), Complicated Urinary Tract Infection | Phase 3 | Status: COMPLETED | Results posted: 2018-09-19